The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Original Article

The Successful Use of Phosphodiesterase Type 5 Inhibitors to Treat the Syndrome of Cor Pulmonale and Prerenal Azotemia with Diuresis of Anasarca (CorPRADA)

Authors: Paul Bruce Berez, MD

Abstract


Background: The occurrence of deteriorating renal function test results along with the attempts at diuresis of anasarca has been described but not named, and no solution other than the standard treatment of related medical conditions such as congestive heart failure (CHF) and reducing or stopping diuretics has been offered. Phosphodiesterase type 5 inhibitors (PD5I) are known to reduce pulmonary hypertension (PH). The PD5Is sildenafil and, just recently, tadalafil, have FDA indications in primary pulmonary hypertension (PPH).


Methods: In this observational study of CorPRADA patients treated with PD5I, 12 out of 19 cases met criteria for inclusion in statistical analysis. Medication reductions/discontinuations generally were made. Pre- and post-treatment data were analyzed using matched pairs.


Results: There were significant improvements in edema, glomerular filtration rate (GFR), weight, and loop diuretic dosage required, while strong trends were seen in urine output per day and urine output per unit loop diuretic per day.


Conclusion: The identification of CorPRADA and the use of standard treatments for PH plus PD5I medication show promise in achieving successful diuresis of anasarca while stabilizing or improving renal function simultaneously.



This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.Alam S, Palevsky HI. Standard therapies for pulmonary arterial hypertension. Clin Chest Med 2007;28:91–115.
 
2.Wang DJ, Gottlieb SS. Diuretics: still the mainstay of treatment. Crit Care Med 2008;36(suppl 1):S89–S94.
 
3.Cleland MD, Coletta A, Witte K. Practical applications of intravenous diuretic therapy in decompensated heart failure. Am J Med 2006;119:S26–S36.
 
4.Guazzi M, Tumminello G, Di Marco F, et al. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 2004;44:2339–2348.
 
5.Singh TS, Kumar D, Basu S, Panja M, Mitra B. Tadalafil in the management of severe pulmonary artery hypertension. Indian Heart J 2006 Jan–Feb;58(1):52–53. PubMed PMID: 18984932. This was accessed 12/01/09
 
6.Hazell L, Cornelius V, Wilton LV, et al. The Safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16,129 patients. BJU Int 2009;103:506–514.
 
7.Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration equation from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999;130:460–470.
 
8.Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, et al. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int 2005;68:2131–2142.
 
9.Schrier RW, Abraham MD. Hormones and hemodynamics in heart failure. N Engl J Med 1999;341:577–585.
 
10.Gami AS. (2008). Sleep apnea and cardiovascular disease. In: Libby P. (Ed.) Braunwald's heart disease: A textbook of cardiovascular medicine. (8th ed.) p. 1918. Philadelphia, Saunders.